| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 10.665.455 $ | 95,63 | 111.675 | ||||||
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 659.333 $ | 5,91 | 5.064 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 542.325 $ | 4,86 | 4.165 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 501.164 $ | 4,49 | 1.955 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 492.837 $ | 4,42 | 5.726 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 466.332 $ | 4,18 | 812 | |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 414.565 $ | 3,72 | 1.783 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 404.973 $ | 3,63 | 2.077 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 392.708 $ | 3,52 | 1.935 | |
| Waters Corp | Waters Corp | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 390.516 $ | 3,50 | 1.035 | |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 388.066 $ | 3,48 | 274 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 383.436 $ | 3,44 | 1.528 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 329.199 $ | 2,95 | 690 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 326.069 $ | 2,92 | 5.948 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 291.491 $ | 2,61 | 3.493 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 278.086 $ | 2,49 | 722 | |
| Bio-Techne Corp | Bio-Techne Corp | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 274.302 $ | 2,46 | 3.805 | |
| Illumina Inc | Illumina Inc | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 268.476 $ | 2,41 | 1.309 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 246.943 $ | 2,21 | 1.579 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 236.769 $ | 2,12 | 1.981 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 236.030 $ | 2,12 | 540 | |
| IQVIA Holdings Inc | IQVIA Holdings Inc | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 218.334 $ | 1,96 | 929 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 213.455 $ | 1,91 | 250 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 200.538 $ | 1,80 | 2.600 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 190.986 $ | 1,71 | 1.145 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 189.943 $ | 1,70 | 1.797 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 170.090 $ | 1,53 | 1.050 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 157.817 $ | 1,42 | 4.654 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 148.435 $ | 1,33 | 875 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 141.657 $ | 1,27 | 2.169 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 141.476 $ | 1,27 | 649 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 136.846 $ | 1,23 | 2.280 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 135.584 $ | 1,22 | 723 | |
| Wuxi Biologics Cayman Inc | Wuxi Biologics Cayman Inc | EC | KYG970081173 | Long | Modellwert (Stufe 2) | 130.791 $ | 1,17 | 26.500 | |
| Bruker Corp | Bruker Corp | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 115.877 $ | 1,04 | 1.844 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 106.579 $ | 0,96 | 780 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 85.476 $ | 0,77 | 333 | |
| Alkermes PLC | Alkermes PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 83.871 $ | 0,75 | 1.712 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 77.236 $ | 0,69 | 576 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 72.336 $ | 0,65 | 2.566 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 69.605 $ | 0,62 | 651 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 65.468 $ | 0,59 | 993 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 63.859 $ | 0,57 | 705 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 63.534 $ | 0,57 | 1.632 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 48.610 $ | 0,44 | 493 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 43.106 $ | 0,39 | 2.375 | |
| Avalo Therapeutics Inc | Avalo Therapeutics Inc | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 14.253 $ | 0,13 | 781 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 12.794 $ | 0,11 | 155 | |
| Sagimet Biosciences Inc | Sagimet Biosciences Inc | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 12.002 $ | 0,11 | 1.688 | |
| Eikon Therapeutics Inc | Eikon Therapeutics Inc | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 11.540 $ | 0,10 | 1.253 | |
| Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical Inc | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 11.459 $ | 0,10 | 460 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 8.281 $ | 0,07 | 636 | |
| Gesamt | 10.665.455 $ | 95,63 | 111.675 |